Recombinant Human LAIR2 protein (rFc Tag) (HPLC verified)
种属
Human
纯度
>90 %, SDS-PAGE
>90 %, SEC-HPLC
标签
rFc Tag
生物活性
未测试
验证数据展示
产品信息
| 纯度 | >90 %, SDS-PAGE >90 %, SEC-HPLC |
| 内毒素 | <0.1 EU/μg protein, LAL method |
| 生物活性 |
Not tested |
| 来源 | HEK293-derived Human LAIR2 protein Gln22-Pro152 (Accession# Q6ISS4-1) with a rabbit IgG Fc tag at the C-terminus. |
| 基因ID | 3904 |
| 蛋白编号 | Q6ISS4-1 |
| 预测分子量 | 40.3 kDa |
| SDS-PAGE | 42-50 kDa, reducing (R) conditions |
| 组分 | Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
| 复溶 | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
| 储存条件 |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
| 运输条件 | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
背景信息
LAIR2, or leukocyte-associated immunoglobulin-like receptor 2, is a protein that belongs to the immunoglobulin superfamily. It is highly expressed in the placenta, specifically in the extravillous trophoblasts (EVTs) at the leading edge of the anchoring cell columns invading the maternal decidua. LAIR2 expression has also been noted to be down-regulated in the first trimester of pregnancies destined for preeclampsia, suggesting a potential role in the etiology of this condition. LAIR2 has been implicated in cancer immunotherapy. A study suggests that LAIR-2 can act as a decoy receptor by binding collagen with higher affinity than LAIR-1, potentially releasing LAIR-1-mediated immune suppression. This could be a novel strategy for cancer immunotherapy, particularly for immune-excluded tumors.
参考文献:
1. Founds SA. et al. (2013) Placenta. 34(3):248-55. 2. Ramos MIP. et al. (2021) Elife. 10:e62927.

